Have a feature idea you'd love to see implemented?
Let us know!
SMTI Sanara MedTech Inc
Price (delayed)
$37.32
Market cap
$326.22M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.99
Enterprise value
$341.87M
With a focus on improving patient outcomes through evidence-based healing solutions and services, Sanara MedTech Inc. markets and distributes wound and skin care products and is seeking to offer wound
Highlights
SMTI's quick ratio has soared by 91% YoY and by 37% QoQ
Sanara MedTech's gross profit has increased by 30% YoY and by 8% QoQ
Sanara MedTech's debt has surged by 169% YoY and by 96% QoQ
Sanara MedTech's net income has decreased by 27% QoQ and by 2.3% YoY
Key stats
What are the main financial stats of SMTI
Market
Valuations
Earnings
Shares outstanding
8.74M
Market cap
$326.22M
Enterprise value
$341.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.21
Price to sales (P/S)
4.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.38
Revenue
$78.06M
EBIT
-$6.24M
EBITDA
-$1.42M
Free cash flow
-$1.99M
Per share
Balance sheet
Liquidity
EPS
-$0.99
Free cash flow per share
-$0.23
Book value per share
$4.55
Revenue per share
$9.16
TBVPS
$5.04
Total assets
$88.55M
Total liabilities
$49.09M
Debt
$31.92M
Equity
$39.78M
Working capital
$17.57M
Debt to equity
0.8
Current ratio
2.23
Quick ratio
1.99
Net debt/EBITDA
-11.01
Margins
Efficiency
Dividend
EBITDA margin
-1.8%
Gross margin
90.2%
Net margin
-10.7%
Operating margin
-10.8%
Return on assets
-10.9%
Return on equity
-19.7%
Return on invested capital
-23.3%
Return on capital employed
-8.4%
Return on sales
-8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SMTI stock price
How has the Sanara MedTech stock price performed over time
Intraday
0.11%
1 week
3.67%
1 month
11.5%
1 year
22.36%
YTD
-9.2%
QTD
23.41%
Financial performance
How have Sanara MedTech's revenue and profit performed over time
Revenue
$78.06M
Gross profit
$70.38M
Operating income
-$8.45M
Net income
-$8.36M
Gross margin
90.2%
Net margin
-10.7%
Sanara MedTech's gross profit has increased by 30% YoY and by 8% QoQ
Sanara MedTech's net income has decreased by 27% QoQ and by 2.3% YoY
The company's revenue rose by 25% YoY and by 8% QoQ
The company's operating margin rose by 21% YoY and by 5% QoQ
Growth
What is Sanara MedTech's growth rate over time
Valuation
What is Sanara MedTech stock price valuation
P/E
N/A
P/B
8.21
P/S
4.07
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.38
SMTI's EPS is down by 27% since the previous quarter
The price to book (P/B) is 27% lower than the 5-year quarterly average of 11.2 but 19% higher than the last 4 quarters average of 6.9
SMTI's equity is down by 10% year-on-year and by 4.6% since the previous quarter
The P/S is 46% lower than the 5-year quarterly average of 7.6
The company's revenue rose by 25% YoY and by 8% QoQ
Efficiency
How efficient is Sanara MedTech business performance
Sanara MedTech's return on invested capital has surged by 68% YoY and by 9% QoQ
SMTI's return on sales is up by 38% year-on-year but it is down by 11% since the previous quarter
The company's return on equity fell by 30% QoQ
The company's return on assets fell by 22% QoQ but it rose by 15% YoY
Dividends
What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SMTI.
Financial health
How did Sanara MedTech financials performed over time
The company's total assets is 80% higher than its total liabilities
SMTI's quick ratio has soared by 91% YoY and by 37% QoQ
The company's total liabilities has surged by 56% YoY and by 53% QoQ
Sanara MedTech's debt is 20% lower than its equity
SMTI's debt to equity has surged by 196% year-on-year and by 105% since the previous quarter
Sanara MedTech's debt has surged by 169% YoY and by 96% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.